Supernus Pharmaceuticals (SUPN)

Supernus Pharmaceuticals (SUPN) Blogger Opinions & Sentiment


Blogger Sentiment

Bullish: 66.00%
Sector Average
SUPN Blogger sentiment is based on 3 Blogger Opinions. The Blogger sentiment is more Bearish than other stocks in the Healthcare sector.

Blogger Article Distribution

66% SeekingAlpha
33% MotleyFool
The distribution of articles among the main online Financial Blogging platforms.

Top Blogger Bearish Predictions

Not enough top blogger opinions at this time
Please return soon. This page is being updated.
Recent negative articles by top bloggers.

Top Blogger Bullish Predictions

Supernus Pharmaceuticals: Derisked CNS Drug Portfolio Offers Attractive Buying Opportunity
Recent positive articles by top bloggers.

Financial Blogger Predictions​​

Blogger Name
Blogger Rank
Blogger Sentiment​
Upgrade Banner
Supernus Pharmaceuticals: Derisked CNS Drug Portfolio Offers Attractive Buying Opportunity
Seeking Alpha
Supernus: Product Sales Stretching Higher, But Not Reflected In Economic Leverage
Motley Fool
Despite 1 Major Headwind and Pricey Shares, This Stock Is Still a Buy


What do Seeking Alpha bloggers think of SUPN?
Seeking Alpha’s Zach Bristow has a Neutral Sentiment.
    What do Motley Fool contributors think of SUPN?
    Motley Fool’s Alex Carchidi has a Bullish Sentiment.
      What Is SUPN’s Blogger Sentiment?
      SUPN’s Blogger Sentiment is Bullish.
        What was the most recent blogger prediction for SUPN?
        The most recent blogger prediction for SUPN was made by Edmund Ingham , who was Bullish on the stock.
          How can I follow the stock ratings of top Top Financial Bloggers?
          Head over to our Expert Center to see a list of the Top 100 Financial Bloggers and follow the financial bloggers of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
            Stocks with the Highest Top Blogger Ratings in the Healthcare sector
            SHOTSafety Shot
            PSTTFPrescient Therapeutics Limited
            NURPFNeuren Pharmaceuticals Limited
            AMEUFAnteris Technologies
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis